Showing results (251-260 of 635) with videos related to
Sort By:
Pageof 64
British Journal of Haematology|September 1, 1990
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crisesC Ponzetto, A Guerrasio, C Rosso, et al.Haematologica|December 29, 1998
Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remissionE Ottaviani, G Martinelli, N Testoni, et al.Haematologica|November 24, 1998
Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular levelG Martinelli, E Ottaviani, G Visani, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|November 1, 1993
Hemoperfusion--state of artM Spighi, S Faenza, M Fini, et al.Leukemia & Lymphoma|April 30, 1999
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patientsP Saletti, E Zucca, M Gueneau, et al.Journal of Telemedicine and Telecare|July 23, 2005
Cardiac event recording yields more diagnoses than 24-hour Holter monitoring in patients with palpitationsS Scalvini, E Zanelli, G Martinelli, et al.Tumori|August 1, 1982
Chemotherapy of advanced non-Hodgkin lymphomas: a report of 35 casesG Büchi, U Mazza, C Camaschella, et al.Leukemia Research|April 25, 2006
Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferonM Breccia, D Diverio, F Pane, et al.Blood|July 29, 1998
Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosisC Selleri, J P Maciejewski, F Pane, et al.European Journal of Haematology|March 1, 1994
Repeated PCR in CML during IFN-alpha therapyA M Liberati, E Donti, C Rosso, et al.Pageof 64